Inflammatory Response and Endothelial Dysfunction Following Cardiopulmonary Bypass: Pathophysiology and Pharmacological Targets.


Journal

Recent patents on inflammation & allergy drug discovery
ISSN: 1872-213X
Titre abrégé: Recent Pat Inflamm Allergy Drug Discov
Pays: United Arab Emirates
ID NLM: 101309297

Informations de publication

Date de publication:
2019
Historique:
received: 16 11 2018
revised: 17 07 2019
accepted: 17 07 2019
pubmed: 25 7 2019
medline: 8 5 2020
entrez: 25 7 2019
Statut: ppublish

Résumé

Endothelial injury occurring during cardiopulmonary bypass is a major contributing factor in the development of organ dysfunction, which leads to many of the postoperative complications occurring during cardiac surgery. This narrative review aims to summarize the main mechanisms of cardiopulmonary bypass - related disease, evaluating the unfavorable events leading to tissue injury, with a description of current pharmacologic and non-pharmacologic mechanisms to reduce CPB-related injury. A Medline/Pubmed/Scopus search was conducted using clinical queries with the key terms "cardiac surgery", "cardiopulmonary bypass", "inflammation" and "endothelial injury", and related MeSH terms, until July 2019. The search strategy included meta-analyses, randomized controlled trials, clinical trials, reviews and pertinent references. Patents were searched using the same key terms from https://patents.google.com/, www.uspto.gov, and www.freepatentsonline.com. In this review, we discuss the current knowledge of the mechanisms of vascular endothelial cell injury, the acute inflammatory response, and the regulatory factors that control the extent of vascular injury during extracorporeal circulation, summarizing the main target of anti-inflammatory pharmacologic and non-pharmacologic strategies. Inflammatory response and endothelial dysfunction following cardiopulmonary bypass are the prices to pay for the benefits offered during cardiac surgery procedures. Counteracting the detrimental effect of extracorporeal circulation appears to be crucial to improve clinical outcomes in pediatric and adult cardiac surgery. The intrinsic complexity and the tight interplay of the factors involved might require a holistic approach against inflammation and endothelial response.

Sections du résumé

BACKGROUND BACKGROUND
Endothelial injury occurring during cardiopulmonary bypass is a major contributing factor in the development of organ dysfunction, which leads to many of the postoperative complications occurring during cardiac surgery.
OBJECTIVE OBJECTIVE
This narrative review aims to summarize the main mechanisms of cardiopulmonary bypass - related disease, evaluating the unfavorable events leading to tissue injury, with a description of current pharmacologic and non-pharmacologic mechanisms to reduce CPB-related injury.
METHODS METHODS
A Medline/Pubmed/Scopus search was conducted using clinical queries with the key terms "cardiac surgery", "cardiopulmonary bypass", "inflammation" and "endothelial injury", and related MeSH terms, until July 2019. The search strategy included meta-analyses, randomized controlled trials, clinical trials, reviews and pertinent references. Patents were searched using the same key terms from https://patents.google.com/, www.uspto.gov, and www.freepatentsonline.com.
RESULTS RESULTS
In this review, we discuss the current knowledge of the mechanisms of vascular endothelial cell injury, the acute inflammatory response, and the regulatory factors that control the extent of vascular injury during extracorporeal circulation, summarizing the main target of anti-inflammatory pharmacologic and non-pharmacologic strategies.
CONCLUSION CONCLUSIONS
Inflammatory response and endothelial dysfunction following cardiopulmonary bypass are the prices to pay for the benefits offered during cardiac surgery procedures. Counteracting the detrimental effect of extracorporeal circulation appears to be crucial to improve clinical outcomes in pediatric and adult cardiac surgery. The intrinsic complexity and the tight interplay of the factors involved might require a holistic approach against inflammation and endothelial response.

Identifiants

pubmed: 31339081
pii: IAD-EPUB-99913
doi: 10.2174/1872213X13666190724112644
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

158-173

Informations de copyright

Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Auteurs

Omar Giacinto (O)

Department of Cardiovascular Surgery, Universita Campus Bio-Medico di Roma, Rome, Italy.

Umberto Satriano (U)

Department of Cardiovascular Surgery, Universita Campus Bio-Medico di Roma, Rome, Italy.

Antonio Nenna (A)

Department of Cardiovascular Surgery, Universita Campus Bio-Medico di Roma, Rome, Italy.

Cristiano Spadaccio (C)

Department of Cardiac Surgery, Golden Jubilee National Hospital, Glasgow, United Kingdom.

Mario Lusini (M)

Department of Cardiovascular Surgery, Universita Campus Bio-Medico di Roma, Rome, Italy.

Ciro Mastroianni (C)

Department of Cardiovascular Surgery, Universita Campus Bio-Medico di Roma, Rome, Italy.

Francesco Nappi (F)

Department of Cardiac Surgery, Centre Cardiologique du Nord de Saint-Denis, Paris, France.

Massimo Chello (M)

Department of Cardiovascular Surgery, Universita Campus Bio-Medico di Roma, Rome, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH